青島雙星:錦湖的電動車專用輪胎Majesty 9 Solus TA91 EV已正式為特斯拉Model Y配套
格隆匯7月27日丨有投資者向青島雙星(000599.SZ)提問,“看有新聞報道錦湖輪胎正給特斯拉Model Y供貨,請問是否屬實?錦湖輪胎現在業績如何,能否滿足資產注入的要求?”
青島雙星迴複稱,錦湖的電動車專用輪胎Majesty 9 Solus TA91 EV已正式為特斯拉Model Y配套,展現的不僅是高超的產品,更重要的是全球領先的數字仿真設計體系。今年一季度,錦湖輪胎收入增長35%,實現銷售額近萬億韓元,營業利潤545億韓元,利潤率達5.5%,控股股東雙星集團將積極推動錦湖輪胎不斷提高盈利能力,根據實際情況擇機選擇有利於雙星發展的方式解決同業競爭。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.